Bicocca Open Archive

Logo unimib boa
CRISTOFERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.480
AS - Asia 3.331
EU - Europa 3.238
SA - Sud America 573
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 11.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.387
SG - Singapore 1.195
IT - Italia 955
CN - Cina 664
VN - Vietnam 580
RU - Federazione Russa 537
HK - Hong Kong 500
BR - Brasile 458
SE - Svezia 453
DE - Germania 452
IE - Irlanda 263
GB - Regno Unito 190
IN - India 82
KR - Corea 70
FR - Francia 67
AR - Argentina 57
FI - Finlandia 56
ID - Indonesia 52
NL - Olanda 50
CA - Canada 46
AT - Austria 30
MX - Messico 29
UA - Ucraina 28
PL - Polonia 25
TR - Turchia 25
ES - Italia 24
IQ - Iraq 24
MY - Malesia 23
DK - Danimarca 22
BD - Bangladesh 21
ZA - Sudafrica 18
BE - Belgio 16
EC - Ecuador 16
JP - Giappone 15
IL - Israele 13
PK - Pakistan 12
CO - Colombia 11
LT - Lituania 11
PY - Paraguay 11
PT - Portogallo 9
UZ - Uzbekistan 9
TW - Taiwan 8
GR - Grecia 7
RS - Serbia 7
VE - Venezuela 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
JO - Giordania 6
MA - Marocco 6
NO - Norvegia 6
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 6
CL - Cile 5
ET - Etiopia 5
KE - Kenya 4
MM - Myanmar 4
BO - Bolivia 3
HN - Honduras 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DZ - Algeria 2
GA - Gabon 2
GD - Grenada 2
GH - Ghana 2
IR - Iran 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PE - Perù 2
TJ - Tagikistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 11.672
Salva come PNG Salva come JPEG
Città #
Ann Arbor 862
Singapore 746
Hong Kong 493
Ashburn 437
Frankfurt am Main 353
Milan 325
Dublin 248
Fairfield 231
Chandler 220
Wilmington 181
New York 172
Ho Chi Minh City 168
Hefei 152
Chicago 147
Hanoi 131
Beijing 123
Los Angeles 121
Santa Clara 110
Woodbridge 104
London 99
Dallas 97
Seattle 96
Houston 88
Cambridge 81
Princeton 72
Shanghai 68
Seoul 66
Rome 57
Buffalo 54
São Paulo 54
Dearborn 44
Moscow 43
The Dalles 41
Jakarta 40
Helsinki 37
Lawrence 35
Munich 29
Altamura 28
Monza 27
Florence 25
Boardman 21
Haiphong 21
San Diego 21
Warsaw 21
Denver 18
Nuremberg 18
Turin 18
Pune 17
Council Bluffs 16
Nanjing 16
Orem 16
Penang 16
Poplar 16
Biên Hòa 15
Brussels 15
Ninh Bình 15
Rio de Janeiro 15
Brooklyn 14
Jacksonville 14
Salt Lake City 14
Tokyo 14
Atlanta 13
Can Tho 13
Chennai 13
Da Nang 13
Stockholm 13
Vienna 13
Andover 12
Bologna 12
Toronto 12
Ha Long 11
Johannesburg 11
Mexico City 11
Montreal 11
Phoenix 11
Bari 10
Guarulhos 10
Mumbai 10
Paris 10
Boston 9
Campinas 9
Columbus 9
Elk Grove Village 9
Guangzhou 9
Hải Dương 9
Lappeenranta 9
Modena 9
Padova 9
Seregno 9
Tampa 9
Thái Nguyên 9
Turku 9
Curitiba 8
Detroit 8
Lisbon 8
Naples 8
San Francisco 8
San Jose 8
Tashkent 8
Ankara 7
Totale 7.245
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 520
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 344
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 336
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 288
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 273
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 271
Precision medicine in primary biliary cholangitis 270
Risk stratification in primary sclerosing cholangitis 269
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 268
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 266
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 263
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 256
Endocrinology and Metabolic Diseases (Including Diabetes) 255
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 238
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 238
New Therapeutic Targets in Autoimmune Cholangiopathies 229
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 228
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 218
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 209
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 206
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 205
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 204
Prognostic models in primary biliary cholangitis 204
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 199
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 196
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 191
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 187
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 184
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 182
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 179
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 177
Artificial intelligence for precision medicine in autoimmune liver disease 176
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 172
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 167
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 161
The immunobiology of female predominance in primary biliary cholangitis 158
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 157
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 157
Fibrocystic liver disease 157
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 146
An update on novel pharmacological agents for primary sclerosing cholangitis 144
A Smooth Esophageal Stricture Causing Dysphagia 137
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 134
X marks the spot in autoimmunity 134
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 134
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 132
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 127
Non-invasive imaging biomarkers in chronic liver disease 125
The Role of Epigenetics in Primary Biliary Cholangitis 124
Individualizing Care: Management Beyond Medical Therapy 124
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 121
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 117
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 115
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 112
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 107
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 106
Antioxidant treatment for acute pancreatitis 103
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 98
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 97
Systematic review-Pancreatic involvement in inflammatory bowel disease 95
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 87
Transient elastography in chronic liver disease: beware to the cut-offs! 86
Primary Sclerosing Cholangitis 83
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 82
Individualizing Care: Management Beyond Medical Therapy 74
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 72
Elastography in Autoimmune Liver Diseases 70
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 48
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 47
Totale 12.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.228
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 121 101 130 89 78 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20252.845 195 303 153 143 233 130 191 111 302 421 260 403
2025/20263.732 934 531 494 770 683 320 0 0 0 0 0 0
Totale 12.039